CrossrefInfokarte
Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients
Otorhinolaryngology-Head and Neck Surgery · 2016
DOI: 10.15761/ohns.1000113 ↗Abstract
Kein Abstract verfügbar.
EUVIMED